ABBV Stock Rises More Than 4% in a Month: Time to Buy, Hold or Sell?Zacks Investment Research • Wednesday
Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 MedicationsPRNewsWire • 11/08/26
2 Defensive Healthcare Stocks Hitting New 52-Week Highs: ABBV & LLYZacks Investment Research • 11/06/26
Exxon Mobil Just Raised Its Dividend for the 44th Year. Here Are 3 More Wall Street Favorites24/7 Wall Street • 11/04/26
Allergan Aesthetics to Present New Research on Aesthetic Care Following Medical Weight Loss and Evolving Patient Needs at ASDS 2026PRNewsWire • 11/03/26
ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline ProgressZacks Investment Research • 11/02/26
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027?The Motley Fool • 11/02/26
2 Safe S&P 500 Healthcare Dividend Stocks Boomers Can Buy and Hold Forever24/7 Wall Street • 11/02/26
Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's ComboThe Motley Fool • 11/02/26
Emerson Among 14 Dividend Growth Companies To Announce Annual Dividend Increases In First Half Of NovemberSeeking Alpha • 11/01/26